AI Applications for Drug Discovery and Development is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Informa

Barry Bedell
CEO & CSO at Biospective Inc., Canada

Profile

Dr. Barry J. Bedell is Co-Founder of Biospective Inc., Associate Professor of Neurology & Neurosurgery at McGill University, and Research Scientist at the Research Institute of the McGill University Health Centre.  Dr. Bedell is an internationally-recognized expert in multi-modality studies of diseases of the central nervous system (CNS).  With a background in medical imaging and neuropathology, Dr. Bedell has extensive experience working closely with the pharmaceutical industry, from preclinical studies through late-phase clinical trials.  Most recently, he has been active in the integration of mobile, wearable, and AI technologies into clinical research studies.  Dr. Bedell holds a Ph.D. in Medical Physics from the University of Texas/M.D. Anderson Cancer Center, and an M.D. degree from McGill University.

Barry Bedell's Network

Agenda Sessions

  • How conversational AI can improve the patient experience in clinical trials

    , 10:30am